Dr. VanWagner’s methodologic research interests are in the areas of epidemiology and risk prediction using large administrative, clinical and research databases.
She has a broad interest in the areas of Obesity, Cardiovascular disease, and Liver Transplantation Research. Her work focuses specifically in patients with Nonalcoholic Fatty Liver Disease (NAFLD) and in prevention and management of cardiac diseases among liver transplant candidates and recipients.
Dr. VanWagner is a former recipient of an Individual (parent F32) National Service Research Award (NRSA) from the National Heart, Lung, and Blood Institute (NHLBI) with additional funding from the American Liver Foundation and Alpha Omega Alpha Foundation. She is currently funded by the Northwestern University Clinical and Translational Sciences Institute (KL2) “Prediction of NAFLD Using a Life Course Approach”. The objective of this grant is to understand how dynamic changes in serially measured lifestyle (e.g., diet) and physiologic (e.g., insulin resistance) factors throughout adulthood effect the development of NAFLD and heart disease in middle age.